O33 Longitudinal assessment of biomarkers in NOBILITY, a randomized, phase II clinical trial of obinutuzumab for treatment of proliferative lupus nephritis
R. Furie, Sander W Tas, Ana Malvar, Cary M Looney, Harini Raghu, Veronica G Anania, Ashley Mao, Thomas Schindler, Elsa Martins, Jorge A Ross Terres, Edward M Vital
{"title":"O33 Longitudinal assessment of biomarkers in NOBILITY, a randomized, phase II clinical trial of obinutuzumab for treatment of proliferative lupus nephritis","authors":"R. Furie, Sander W Tas, Ana Malvar, Cary M Looney, Harini Raghu, Veronica G Anania, Ashley Mao, Thomas Schindler, Elsa Martins, Jorge A Ross Terres, Edward M Vital","doi":"10.1136/lupus-2024-el.42","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":517941,"journal":{"name":"Oral Presentations","volume":"57 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Presentations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/lupus-2024-el.42","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
